The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation
Journal Article
·
· Blood; (United States)
OSTI ID:5365894
Between 1975 and 1978, 51 patients with favorable histology non-Hodgkin's lymphomas, pathologic stage III-IV, were treated prospectively on a randomized treatment protocol. Treatment options were single alkylating agent chemotherapy, combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP), or fractionated whole body irradiation followed by low dose involved field irradiation. The median follow-up interval in this group of patients is not 41 mo. Actuarial survival is excellent, 84% at 4 yr for the entire group, with similar survival observed for each of the three treatment options. Initial complete remission rates (64%, 88%, and 71%) were not significantly different in the three treatment arms. Frequent relapse after initial remission induction was noted, however, with a freedom from relapse at 4 yr of only 25%. The toxicities of the three therapies were acceptable. Acute complications of therapy were most numerous in the group of patients treated with CVP; however, long-term hematologic depression was most commonly observed in patients treated with whole body irradiation. In general, hematologic complications were more frequent among patients who had marrow involvement and intact spleens at the time of initial therapy. The relationship of this study to other clinical trials in the management of patients with advanced stage favorable histology lymphomas and its implications for future clinical trials are discussed.
- OSTI ID:
- 5365894
- Journal Information:
- Blood; (United States), Journal Name: Blood; (United States) Vol. 58:3; ISSN BLOOA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Improved five year survival after combined radiotherapy-chemotherapy for Stage I-II non-Hodgkin's lymphoma
Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease
Journal Article
·
Thu Jan 31 23:00:00 EST 1980
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5006387
Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas
Journal Article
·
Wed Feb 28 23:00:00 EST 1979
· Cancer; (United States)
·
OSTI ID:6312030
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease
Journal Article
·
Wed Jan 31 23:00:00 EST 1979
· Cancer; (United States)
·
OSTI ID:5368629
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
550900 -- Pathology
560151 -- Radiation Effects on Animals-- Man
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL TISSUES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BONE MARROW
CHEMOTHERAPY
DISEASES
DOSES
EXTERNAL IRRADIATION
FRACTIONATED IRRADIATION
HEMATOLOGY
HEMATOPOIETIC SYSTEM
IRRADIATION
LOCAL IRRADIATION
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
SPLEEN
THERAPY
TISSUES
WHOLE-BODY IRRADIATION
550900 -- Pathology
560151 -- Radiation Effects on Animals-- Man
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL TISSUES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BONE MARROW
CHEMOTHERAPY
DISEASES
DOSES
EXTERNAL IRRADIATION
FRACTIONATED IRRADIATION
HEMATOLOGY
HEMATOPOIETIC SYSTEM
IRRADIATION
LOCAL IRRADIATION
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
SPLEEN
THERAPY
TISSUES
WHOLE-BODY IRRADIATION